PharmiWeb

Early Intervention for Asymptomatic Severe Aortic Stenosis Delivers Cost Savings, System Efficiencies, and Better Patient Outcomes

First-of-a-kind health economics study found lifetime per-patient savings from early TAVR range from £1,788 in the UK to CHF ...

Caranx Medical Announces First Clinical Use of the TAVIPILOT Soft, Cleared by FDA for Commercial in July

Caranx Medical ("Caranx"), a French medical device company specializing in the development of an autonomous robot to democratize access to Transcatheter Aortic Valve Implantation (TAVI), a lifesaving ...
MassDevice

Caranx announces first clinical use of autonomous robot for TAVI

Caranx Medical announced the first clinical use of its TaviPilot Soft platform for robotic transcatheter aortic valve ...

Caranx Medical Announces First Clinical Use of the TAVIPILOT Soft, Cleared by FDA for Commercial in July: the World First AI Software for Real-Time Intra-Operative Guidance of ...

Caranx Medical ("Caranx"), a French medical device company specializing in the development of an autonomous robot to democratize access to Transcatheter Aortic Valve Implantation (TAVI), a lifesaving ...
PharmiWeb

Pediatric Interventional Cardiology Market is Estimated to Cross CAGR of 6-8% by the End of 2029

Pediatric interventional cardiology has emerged as a specialized field that integrates pediatric cardiology with interventional techniques to diagnose and treat heart defects in infants, children, and ...